Blood

Journal Title：Blood

Blood, the official journal of the American Society of Hematology, published online and in print, provides an international forum for the publication of original articles describing basic laboratory, translational, and clinical investigations in hematology. Acceptance of manuscripts is based on the originality and importance of the observations or investigations, the quality of the work and validity of the evidence, the clarity of presentation, and the relevance to our readership and field. All articles are expected to be concise, well organized and clearly written. Authors submit a manuscript with the understanding that the manuscript (or its essential substance) has not been published other than as an abstract in any language or format and is not currently submitted elsewhere for print or electronic publication.

Primary research articles will be published under the following scientific categories: Clinical Trials and Observations; Gene Therapy; Hematopoiesis and Stem Cells; Immunobiology and Immunotherapy scope; Myeloid Neoplasia; Lymphoid Neoplasia; Phagocytes, Granulocytes and Myelopoiesis; Platelets and Thrombopoiesis; Red Cells, Iron and Erythropoiesis; Thrombosis and Hemostasis; Transfusion Medicine; Transplantation; and Vascular Biology. Papers can be listed under more than one category as appropriate. Authors are invited to contact the Editor-in-Chief prior to submission if they are uncertain whether their work falls within the general scope of the journal.

Blood 是美国血液学会的官方期刊，以在线和印刷形式出版，为发表描述血液学基础实验室、转化和临床研究的原创文章提供了一个国际论坛。稿件的接受是基于观察或调查的原创性和重要性、工作质量和证据的有效性、表述的清晰度以及与我们的读者群和领域的相关性。所有文章都应简明扼要，条理清晰，文笔清晰。作者在提交稿件时理解该稿件（或其基本内容）除了以任何语言或格式的摘要以外没有发表过，并且目前没有在其他地方提交以进行印刷或电子出版。

主要研究文章将在以下科学类别下发表：临床试验和观察；基因治疗;造血和干细胞；免疫生物学和免疫治疗范围；髓样瘤；淋巴样瘤；吞噬细胞、粒细胞和骨髓生成；血小板和血小板生成；红细胞、铁和红细胞生成；血栓形成和止血；输血医学；移植；和血管生物学。论文可以酌情列在一个以上的类别下。如果作者不确定自己的工作是否属于期刊的一般范围，请在投稿前与主编联系。

Blood创刊于1946年，由AMER SOC HEMATOLOGY出版商出版，收稿方向涵盖医学 - 血液学全领域，在行业领域中学术影响力很大，属于TOP期刊，国际一流期刊，关注度和专业度非常高，所以对原创文章要求创新性很高，过审难度很高，如果您有志于TOP期刊，建议关注此刊。平均审稿速度约1.0个月，影响因子指数17.543，该期刊近期没有被列入国际期刊预警名单，广大学者值得一试。